ARCHIVES

New Drug for Lymphoma Enters Phase II Trial

This article is from The Cancer Letter archive.

Vol. 27 No. 5 | May 28, 2004

Download PDF Visit The Full Archive

Related Articles

Broder Encourages Support Of Drug Development Programs

March 10, 1995

I-ELCAP Moves From Weill Cornell To Arizona State; PIs Move To Mount Sinai.

January 22, 2010

DCT Board Okays Kaposi Study, Blocks Monitoring Plan

February 26, 1982

In Brief: Elion Elected Member Of National Academy; Bleyer Heads M.D. Anderson Pediatrics

May 4, 1990

Grantees May Get More Freedom In Adjusting budgets

February 21, 1975

Erbitux Plus Radiation, Chemo, Appears To Provide CRs In A Small Phase II Study

February 23, 2007